Actinomycin D for fibrosis management in ophthalmic implant surgery
Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
De Gruyter
2019-09-01
|
| Sarja: | Current Directions in Biomedical Engineering |
| Aiheet: | |
| Linkit: | https://doi.org/10.1515/cdbme-2019-0121 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|